Navigation Links
Cephalon Reports Another Strong Quarter
Date:10/28/2008

149 49,465

Net cash provided by operating

activities 282,777 274,321

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchases of property and

equipment (55,689) (70,887)

Acquisition of intangible assets (25,575) (99,152)

Investment in third party (6,242) -

Proceeds from sale of investment

in third party - 12,291

Sales and maturities of

available-for-sale investments 7,596 28,212

Purchases of available-for-sale

investments - (71,398)

Net cash used for investing

activities (79,910) (200,934)

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from exercises of

common stock options 37,185 74,375

Windfall tax benefits from

stock-based compensation 4,592 9,934

Acquisition of treasury stock (24) (128)

Payments on and retirements of

long-term debt (216,093) (2,902)

Net cash (used for) provided

by financing activities (174,340) 81,279

EFFECT OF EXCHANGE RATE CHANGES ON

CASH AND CASH EQUIVALENTS (601) 10,804

NET INCREASE IN CASH AND CASH

EQUIVALENTS 27,926 165,470

CASH AND CASH EQUIVALENTS, BEGINNING

OF PERIOD 818,669 496,512

CASH AND CASH EQUIVALENTS, END OF

PERIOD
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... College, PA (PRWEB) August 27, 2014 ... Simulation Software with new features for the biomedical ... is an enhanced Biological Thermal Sensor, exclusive to the ... a specialty version of XFdtd, developed to calculate the ... export functionality has been added to all versions to ...
(Date:8/26/2014)... the thinnest-possible semiconductor, a new class of nanoscale ... , The University of Washington researchers have demonstrated ... be connected in an atomically seamless fashion known ... basis for next-generation flexible and transparent computing, better ... "Heterojunctions are fundamental elements of electronic and photonic ...
(Date:8/26/2014)... 26, 2014 An analysis by Replikins, Ltd. ... Mers CoV virus strains has revealed extensive ... 2012.  This conservation and sharing of specific Replikin gene ... Blocker-Vaccine™ candidate, as it did for the H5N1 influenza ... which have been found to be effective (1,2). ...
(Date:8/26/2014)... to the growing case for graphene being bumped ... in the high-tech world by the two-dimensional semiconductors ... researchers led by a scientist with the U.S. ... (Berkeley Lab) has reported the first experimental observation ... The recorded charge transfer time clocked in at ...
Breaking Biology Technology:Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3Scientists craft atomically seamless, thinnest-possible semiconductor junctions 2Competition for graphene 2
... today announced that Pat Basu, M.D., M.B.A. , ... as Chief Medical Officer. Dr. Basu has just completed ... a White House Fellow, America,s most prestigious and selective ... will play a critical role in advancing vRad,s efforts, ...
... Sequenom, Inc. (NASDAQ: SQNM ), a life ... the launch of its iPLEX ADME PGx panel developed ... distribution, metabolism, and excretion (ADME). This Research Use Only ... polymorphisms (SNP), insertions and deletions (INDELS) and copy number ...
... HILL, MA -- Boston College researchers have discovered two ... chemical vapor deposition, finding a disorderly tangle of tube ... nanoscopic tubes, according to a report in the latest ... using a thin layer of catalyst, Professor of Physics ...
Cached Biology Technology:vRad Adds White House Fellow, Dr. Pat Basu, to Its Leadership Teams 2Sequenom Introduces iPLEX® ADME PGx Panel on MassARRAY® System 2Sequenom Introduces iPLEX® ADME PGx Panel on MassARRAY® System 3Boston College Researchers discover 2 early stages of carbon nanotube growth 2
(Date:8/27/2014)... century-old museum specimens hold clues to how global climate change ... kill trees and the news is not good. , ... and maple trees in warmer urban areas, which raises the ... says Dr. Elsa Youngsteadt, a research associate at NC State ... "More scale insects would be a problem, since scales can ...
(Date:8/26/2014)... Louis have developed algorithms to identify weak spots in ... The technology, which needs to be refined before it ... minor strains and tiny injuries in the body,s tissues ... available online Aug. 27 in the Journal of ... the nexus of the physical and life sciences. , ...
(Date:8/26/2014)... of harmful bacteria, biofilms make the treatment of ... biofilm pose a significant health risk due to ... biofilm-protected bacteria account for some 80 percent of ... to 1,000 times more resistant to antibiotics than ... have stumbled onto a magic bullet," said David ...
Breaking Biology News(10 mins):Museum specimens, modern cities show how an insect pest will respond to climate change 2New technology may identify tiny strains in body tissues before injuries occur 2New technology may identify tiny strains in body tissues before injuries occur 3Breakthrough antibacterial approach could resolve serious skin infections 2Breakthrough antibacterial approach could resolve serious skin infections 3
... , Journal of Visualized Experiments , details the ... polymer, SurgiLux, was developed by scientists at the University ... from chitin, which is found in fungal cell walls ... allows SurgiLux to form low energy bonds between the ...
... Institute for Medical Research has been awarded a $1 ... which is administered by the National Institute for Occupational ... for Disease Control and Prevention (CDC), the National Institute ... comprehensively study the overall physical, mental and socioeconomic impact ...
... Manoel Manghi from Toulouse University in France and his colleagues ... to a double stranded molecule of DNA when it is ... be published in EPJ E . Instead of using ... settings, the authors focused on using a theoretical model to ...
Cached Biology News:New bio-adhesive polymer demonstrated in JoVE 2Feinstein Institute receives $1 million grant to study impact of World Trade Center attacks on responders 2
... can be induced prior to DNA purification ... stability of single-copy BACs with the high ... vectors. The kits provide the linearized vector ... screening system) necessary to create a 10X ...
...
... 3T3 cells were cultured in DMEM with 4 ... of growth. In order to keep the ... in acetone-methanol. The cells are arrayed on ... each wells surface specifically treated to enhance cellular ...
... Systems provide rapid, precise localization of ... frozen or paraffin-embedded tissue, cytospins and ... facilitate double or triple labeleing experiments, ... with primary antibodies of different animal ...
Biology Products: